Author:
Muiño Elena,Maisterra Olga,Jiménez-Balado Joan,Cullell Natalia,Carrera Caty,Torres-Aguila Nuria P.,Cárcel-Márquez Jara,Gallego-Fabrega Cristina,Lledós Miquel,González-Sánchez Jonathan,Olmos-Alpiste Ferran,Espejo Eva,March Álvaro,Pujol Ramón,Rodríguez-Campello Ana,Romeral Gemma,Krupinski Jurek,Martí-Fàbregas Joan,Montaner Joan,Roquer Jaume,Fernández-Cadenas Israel
Abstract
AbstractCADASIL is a small vessel disease caused by mutations in NOTCH3 that lead to an odd number of cysteines in the EGF-like repeat domain, causing protein misfolding and aggregation. The main symptoms are migraine, psychiatric disturbances, recurrent strokes and dementia, being executive function characteristically impaired. The molecular pathways altered by this receptor aggregation need to be studied further. A genome-wide transcriptome study (four cases paired with three healthy siblings) was carried out, in addition to a qRT-PCR for validation purposes (ten new cases and eight new controls). To study the expression profile by cell type of the significant mRNAs found, we performed an in situ hybridization (ISH) (nine cases and eight controls) and a research in the Single-nuclei Brain RNA-seq expression browser (SNBREB). Pathway analysis enrichment was carried out with Gene Ontology and Reactome. Neuropsychological tests were performed in five of the qRT-PCR cases. The two most significant differentially expressed mRNAs (BANP, p-value = 7.23 × 10–4 and PDCD6IP, p-value = 8.36 × 10–4) were selected for the validation study by qRT-PCR. Additionally, we selected two more mRNAs (CAMK2G, p-value = 4.52 × 10–3 and E2F4, p-value = 4.77 × 10–3) due to their association with ischemic neuronal death. E2F4 showed differential expression in the genome-wide transcriptome study and in the qRT-PCR (p = 1.23 × 10–3), and it was upregulated in CADASIL cases. Furthermore, higher E2F4 expression was associated with worse executive function (p = 2.04 × 10–2) and attention and information processing speed (IPS) (p = 8.73 × 10–2). In situ hibridization showed E2F4 expression in endothelial and vascular smooth vessel cells. In silico studies indicated that E2F4 is also expressed in brain endothelial cells. Among the most significant pathways analyzed, there was an enrichment of vascular development, cell adhesion and vesicular machinery terms and autophagy process. E2F4 is more highly expressed in the skin biopsy of CADASIL patients compared to controls, and its expression is present in endothelial cells and VSMCs. Further studies are needed to understand whether E2F4 could be useful as a biomarker, to monitor the disease or be used as a therapeutic target.
Funder
Instituto de Salud Carlos III
Agència de Gestió d'Ajuts Universitaris i de Recerca
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Moreton, F. C., Razvi, S. S. M. M., Davidson, R. & Muir, K. W. Changing clinical patterns and increasing prevalence in CADASIL. Acta Neurol. Scand. 130, 197–203 (2014).
2. Bianchi, S. et al. CADASIL in central Italy: A retrospective clinical and genetic study in 229 patients. J. Neurol. 262, 134–141 (2015).
3. Rutten, J. W. et al. Archetypal NOTCH3 mutations frequent in public exome: Implications for CADASIL. Ann. Clin. Transl. Neurol. 3, 844–853 (2016).
4. Rutten, J. W. et al. The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant. Genet. Med. 0, 6–11 (2018).
5. Duering, M. et al. Co-aggregate formation of CADASIL-mutant NOTCH3: A single-particle analysis. Hum. Mol. Genet. 20, 3256–3265 (2011).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献